Literature DB >> 28971231

Effects of morphine on place conditioning and ERK1/2 phosphorylation in the nucleus accumbens of psychogenetically selected Roman low- and high-avoidance rats.

Michela Rosas1, Simona Porru1, Marta Sabariego2, Maria Antonietta Piludu1, Osvaldo Giorgi1, Maria G Corda1, Elio Acquas3,4.   

Abstract

RATIONALE: Extracellular signal-regulated kinase (ERK1/2) phosphorylation is critical for neuronal and behavioural functions; in particular, phosphorylated ERK1/2 (pERK1/2) expression in the nucleus accumbens (Acb) of the rat is stimulated by addictive drugs with the exception of morphine, which decreases accumbal ERK1/2 phosphorylation in the Sprague-Dawley and Wistar rats. The psychogenetically selected Roman low- (RLA) and high-avoidance (RHA) rats differ behaviourally and neurochemically in many responses to addictive drugs. In particular, morphine elicits a greater increment in locomotor activity and in dopamine transmission in the Acb of RHA vs RLA rats. However, the effects of morphine on place conditioning (conditioned place preference (CPP)) and ERK1/2 phosphorylation in the Roman lines remain unknown. OBJECTIVES AND METHODS: To characterize in the Roman lines the reinforcing properties of morphine (i.e. morphine-elicited CPP acquisition) and the relationship between these properties and its effects on ERK1/2 phosphorylation in the Acb, the behavioural effects of morphine were evaluated in a place-conditioning apparatus and ERK1/2 phosphorylation was assessed by immunohistochemistry in the shell and core subregions of the Acb of rats both acutely administered with morphine or undergoing conditioning.
RESULTS: Morphine elicited CPP in both Roman lines and decreased pERK1/2 expression in the Acb of RLA but not RHA rats. Such decrease was prevented by conditioning.
CONCLUSIONS: These findings indicate that the selective breeding of the Roman lines has generated a divergence, in terms of morphine-elicited pERK1/2 expression but not of morphine-elicited CPP, between RLA and RHA rats and sustain the observation that changes in pERK1/2 expression in the Acb are not a requisite for the reinforcing effects of morphine.

Entities:  

Keywords:  Conditioned place preference (CPP); Extracellular signal-regulated kinase (ERK); Morphine; Nucleus accumbens; Phosphorylated ERK (pERK); Psychogenetic selection; RHA rats; RLA rats

Mesh:

Substances:

Year:  2017        PMID: 28971231     DOI: 10.1007/s00213-017-4740-4

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

1.  Blockade of morphine-induced place preference by diazepam in mice.

Authors:  T Suzuki; M Tsuda; M Funada; M Misawa
Journal:  Eur J Pharmacol       Date:  1995-07-14       Impact factor: 4.432

Review 2.  Phenotypic characterization of genetically selected Sardinian alcohol-preferring (sP) and -non-preferring (sNP) rats.

Authors:  Giancarlo Colombo; Carla Lobina; Mauro A M Carai; Gian Luigi Gessa
Journal:  Addict Biol       Date:  2006-09       Impact factor: 4.280

Review 3.  Neonatal handling and environmental enrichment effects on emotionality, novelty/reward seeking, and age-related cognitive and hippocampal impairments: focus on the Roman rat lines.

Authors:  A Fernández-Teruel; R M Escorihuela; B Castellano; B González; A Tobeña
Journal:  Behav Genet       Date:  1997-11       Impact factor: 2.805

4.  Blockade of D-1 receptors by SCH 23390 antagonizes morphine- and amphetamine-induced place preference conditioning.

Authors:  P Leone; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-03-17       Impact factor: 4.432

5.  Relapse (number of detoxifications) in abstinent male alcohol-dependent patients as related to personality traits and types of tolerance to frustration.

Authors:  Melanie Y Baars; Matthias J Müller; Bernd Gallhofer; Petra Netter
Journal:  Neuropsychobiology       Date:  2013-05-14       Impact factor: 2.328

6.  High impulsivity predicts the switch to compulsive cocaine-taking.

Authors:  David Belin; Adam C Mar; Jeffrey W Dalley; Trevor W Robbins; Barry J Everitt
Journal:  Science       Date:  2008-06-06       Impact factor: 47.728

7.  Male Roman high and low avoidance rats show different patterns of copulatory behaviour: comparison with Sprague Dawley rats.

Authors:  Fabrizio Sanna; Maria Giuseppa Corda; Maria Rosaria Melis; Maria Antonietta Piludu; Osvaldo Giorgi; Antonio Argiolas
Journal:  Physiol Behav       Date:  2014-01-25

8.  Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats.

Authors:  Todor V Gerdjikov; Gregory M Ross; Richard J Beninger
Journal:  Behav Neurosci       Date:  2004-08       Impact factor: 1.912

9.  Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone.

Authors:  Ebony M Glover; Michael Davis
Journal:  Psychopharmacology (Berl)       Date:  2008-03-07       Impact factor: 4.530

10.  Role of dopamine D1 receptors and extracellular signal regulated kinase in the motivational properties of acetaldehyde as assessed by place preference conditioning.

Authors:  Liliana Spina; Rosanna Longoni; Stefania Vinci; Federico Ibba; Alessandra T Peana; Giulia Muggironi; Saturnino Spiga; Elio Acquas
Journal:  Alcohol Clin Exp Res       Date:  2010-01-26       Impact factor: 3.455

View more
  2 in total

1.  Effects of docosanyl ferulate, a constituent of Withania somnifera, on ethanol- and morphine-elicited conditioned place preference and ERK phosphorylation in the accumbens shell of CD1 mice.

Authors:  Riccardo Maccioni; Marcello Serra; Jacopo Marongiu; Filippo Cottiglia; Elias Maccioni; Valentina Bassareo; Micaela Morelli; Sanjay B Kasture; Elio Acquas
Journal:  Psychopharmacology (Berl)       Date:  2022-01-28       Impact factor: 4.530

Review 2.  Opioids and Vitamin C: Known Interactions and Potential for Redox-Signaling Crosstalk.

Authors:  Mackenzie Newman; Heather Connery; Jonathan Boyd
Journal:  Antioxidants (Basel)       Date:  2022-06-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.